암 분야 AI

The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.

The North American market for AI in cancer is estimated to increase from $995.6 million in 2024 to reach $2.7 billion by 2029, at a CAGR of 21.6% from 2024 through 2029.

The Asia-Pacific market for AI in cancer is estimated to increase from $476.5 million in 2024 to reach $1.5 billion by 2029, at a CAGR of 26.2% from 2024 through 2029.

Report Scope:

The report highlights AI technology's current and future market potential for cancer applications. It provides a detailed analysis of the market drivers, restraints and opportunities. The report also covers market projections through 2029 and presents a competitive environment and product analysis. The report provides market estimates and forecasts based on application, cancer type and region. By application type, the market is segmented into cancer screening, diagnosis, therapy, drug discovery and development and others. By cancer type, the market is segmented into breast, lung, prostate, gastrointestinal, brain and others. By end user, the market is segmented into hospitals, diagnostic centers, pharmaceutical companies and research institutions. The report includes profiles of the key companies with detailed information about their business segments, financials, product portfolios and recent developments.

By geographical region, the market is segregated into North America, Europe, Asia Pacific and the Rest of the world. The North American region includes countries the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea, Australia and the Rest of Asia-Pacific. For market estimates, data is provided for 2021 and 2022 as the historic years, 2023 as the base year and 2029 as the forecast year.

Report Includes:

• 42 data tables and 44 additional tables
• An up-to-date overview of the global markets for artificial intelligence (AI) in cancer
• Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
• Evaluation of the size of the market for artificial intelligence (AI) in cancer and revenue growth prospects, accompanied by a market share analysis by type, application, end user and region
• Assessment of market dynamics such as drivers, restraints and opportunities
• Coverage of current and emerging applications of AI in cancer and information on theranostics and generative AI tools
• A discussion on ESG challenges and practices in the industry
• Assessment of the vendor landscape, including the market shares of key companies, their product portfolios and financial overviews
• Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments, product launches, and other strategic developments
• Company profiles of major players within the industry, including Siemens Healthineers, GE Healthcare, NVIDIA Corp., and Lunit Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Insights

Chapter 2 Market Overview

• Overview
• Current and Emerging Applications of AI in Cancer
• Diagnosis
• Therapy
• Screening and Early Detection
• Drug Discovery and Development

Chapter 3 Market Dynamics

• Market Dynamics Snapshot
• Market Drivers
• AI in Drug Discovery and Development
• Increasing Incidence of Cancer
• Market Restraints
• Data Collection and Privacy
• False Positives and Bias
• Market Opportunities
• AI-Enabled Hardware Products

Chapter 4 Emerging Technologies

• Introduction
• AI for Multi-Cancer Early Detection
• Theranostics and AI
• Generative AI Tools
• Federated Learning

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis by Cancer Type
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Gastrointestinal Cancer
• Brain Cancer
• Other Cancers
• Market Analysis by Application
• Diagnosis
• Drug Discovery and Development
• Therapy
• Cancer Screening
• Other Applications
• Market Analysis by End User
• Market Size and Forecast
• Hospitals
• Diagnostic Centers
• Pharmaceutical Companies
• Research Institutions
• Geographic Breakdown
• Market Analysis by Region
• Market Size and Forecast
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Overview
• Partnerships
• M&A Activities
• Investments and Funding
• Patent Analysis

Chapter 7 Sustainability in the AI in the Cancer Market

• Introduction
• Sustainability in AI in the Cancer Industry
• Understanding the ESG Data
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• AZRA AI
• CONCERTAI
• GE HEALTHCARE
• ICAD INC.
• LUNIT INC.
• MEDIAN TECHNOLOGIES
• NVIDIA CORP.
• QUEST DIAGNOSTICS INC.
• SIEMENS HEALTHINEERS AG